Advancing the Future of Preclinical Research: Mattek at MPS 2026
Mattek is joining other leaders in biotechnology, pharmaceutical development, and advanced in vitro research to shape the future of human-relevant testing. Connect with us at MPS booth #216 and meet with our team of experts for innovative solutions for safety, efficacy, and translational research.
As industries and regulators continue to advance toward more predictive, non-animal testing strategies, learn how Mattek’s technology supports researchers and product developers with innovative solutions for safety, efficacy, and translational research. Whether you are developing novel therapeutics, ingredients, or consumer products, our team can help guide your testing strategy with scientifically robust, human-relevant approaches.
Meet with an Expert On-Site:
Scientific Poster Presentations
Integration of Incucyte® Workflow and Multi-Organ Toxplate (Kidney, Small Intestine, and Liver) for NAMS-Based Hazard and Risk Assessment of Compounds
Seyoum Ayehunie1, Joeseph Finelli1, Martha Mayo1, Paul Keselman2, Alexander Armento1 1Mattek – Now Part of Sartorius, Ashland, MA, USA. 2Sartorius Stedim North America, Inc., Ann Arbor, MI, USA.
Poster Session 1: May 27, 9:30-11 AM
Use of Patient-Derived 3D Tumoroids Harboring Diverse Mutations to Scaleup Screening of Safety and Efficacy of Metastatic Colorectal Cancer Therapies
Dylan Bryda1, Megan Groves2, Alex Armento1, Anthony Tolcher2, and Seyoum Ayehunie1 1Mattek – Now Part of Sartorius, Ashland, MA, USA. 2Next Oncology, San Antonio, TX, USA.
Poster Session 2: May 27, 3:15-4:45 PM
